ACQUIRED CHROMOSOMAL ABNORMALITY

ACQUIRED CHROMOSOMAL ABNORMALITY was reported 7 times

ACQUIRED CHROMOSOMAL ABNORMALITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
1 CTLA-4-directed Blocking Antibody [EPC] 2 0.0000
2 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
3 Proteasome Inhibitor [EPC] 2 0.0000
4 Topoisomerase Inhibitor [EPC] 1 0.0000
5 Microtubule Inhibitor [EPC] 2 0.0000
6 Platinum-based Drug [EPC] 3 0.0000
7 Alkylating Drug [EPC] 2 0.0000
8 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
9 Retinoid [EPC] 1 0.0000
10 Thalidomide Analog [EPC] 2 0.0000
11 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
12 Factor Xa Inhibitor [EPC] 1 0.0000
13 Corticosteroid [EPC] 2 0.0000